Trigeminal neuralgia future or investigational therapies
|
Trigeminal neuralgia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Trigeminal neuralgia future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Trigeminal neuralgia future or investigational therapies |
|
FDA on Trigeminal neuralgia future or investigational therapies |
|
CDC on Trigeminal neuralgia future or investigational therapies |
|
Trigeminal neuralgia future or investigational therapies in the news |
|
Blogs on Trigeminal neuralgia future or investigational therapies |
|
Risk calculators and risk factors for Trigeminal neuralgia future or investigational therapies |
Despite being treated medically as well as surgery, many patients of trigeminal neuralgia suffer not only from refractory pain but also from the side effects of medications and post surgical complications. This has increased the demand for more precise treatments which, along with pain relief, can also improve the quality of life. Emerging treatment options currently under clinical investigation are a novel sodium channel blocker (CNV1014802) that selectively blocks the Nav1.7 sodium channel, as well as local botulinum neurotoxin type A injections. Non-pharmacological options may include non-invasive electrical stimulation with transcranial direct current stimulation (tDCS), or repetitive transcranial magnetic stimulation (rTMS). All these things are currently under investigation and require further evaluation.[1]
References
- ↑ Obermann, Mark; Katsarava, Zaza; Holle, Dagny (2017). "An update on emerging therapeutic options for the treatment of trigeminal neuralgia". Expert Opinion on Orphan Drugs. 5 (11): 859–863. doi:10.1080/21678707.2017.1394183. ISSN 2167-8707.